NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

biosectinvestor,

Linda already commented that CRL and Sawston will be expected to back one another up. No doubt this plays into reducing any perception of conflict of interest as well as provide necessary approved redundancy should one site become less able to produce or incapacitated for any reason. This pretty much assures a similar pricing structure in place between CDMOs for services rendered. Development of Flaskworks will obviously be in house in Maryland most likely then tested further towards full approval and implementation with the manufacturer with closest ties to NWBO of course. Best wishes.